Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Kansas

Phase 1 cancer trials in Kansas

35 Phase 1 cancer studies are recruiting participants at sites in 5 cities across Kansas as of November 17, 2026, according to ClinicalTrials.gov.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Kansas city with a recruiting study

By research area: Lymphoma (12), Breast Cancer (9), Lung Cancer (7), Prostate Cancer (4), Pancreatic Cancer (3).

Westwood (17), Kansas City (13), Fairway (9), Overland Park (4), Wichita (4).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Kansas

Basic details from each study's public record (the 12 most recently updated of 35). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

    • Phase 1
    • Ages 12 to 120
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Fairway
    Registry record
    NCT04222413 · updated
  2. A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Aktis Oncology, Inc.
    Recruiting in
    Westwood
    Registry record
    NCT07020117 · updated
  3. A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Stemline Therapeutics, Inc.
    Recruiting in
    Fairway
    Registry record
    NCT06638307 · updated
  4. Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Genmab
    Recruiting in
    Westwood
    Registry record
    NCT05579366 · updated
  5. Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Novartis Pharmaceuticals
    Recruiting in
    Kansas City
    Registry record
    NCT07604571 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Kansas on ClinicalTrials.gov.

Lung cancer: recently updated in Kansas

  1. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Fairway · Kansas City · Overland Park · and 1 more U.S. location
    Registry record
    NCT06287775 · updated
  2. Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Overland Park
    Registry record
    NCT06772623 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Kansas on ClinicalTrials.gov.

Prostate cancer: recently updated in Kansas

  1. TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

    • Phase 1/2
    • Ages 18 and older
    • Male participants
    Sponsor
    Novartis Pharmaceuticals
    Recruiting in
    Westwood · Wichita
    Registry record
    NCT07190300 · updated
  2. A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Aktis Oncology, Inc.
    Recruiting in
    Kansas City
    Registry record
    NCT07581184 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Kansas on ClinicalTrials.gov.

Lymphoma: recently updated in Kansas

  1. BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    PeproMene Bio, Inc.
    Recruiting in
    Kansas City
    Registry record
    NCT05370430 · updated
  2. A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Kansas City
    Registry record
    NCT07101328 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Kansas on ClinicalTrials.gov.

Pancreatic cancer: recently updated in Kansas

  1. Lead-212 PSV359 Therapy for Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 to 90
    • All sexes
    Sponsor
    Perspective Therapeutics
    Recruiting in
    Kansas City
    Registry record
    NCT06710756 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Kansas on ClinicalTrials.gov.

Ask about studies in Kansas

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call